- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Innopharmax (4172)
Innopharmax stock price live, this page displays TWO 4172 stock exchange data. View the 4172 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Innopharmax real time stock price chart below.
What Is the Innopharmax Stock Price Today?
The Innopharmax stock price today is 16.00.
What Is the Stock Symbol for Innopharmax?
The stock symbol for Innopharmax is "4172."
What Stock Exchange Does Innopharmax Trade On?
Innopharmax is listed and trades on the TPEX stock exchange.
Is Innopharmax a Good Stock to Buy?
Determining whether Innopharmax—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4172 quote. (ISIN: TW0004172002)
What Is the Innopharmax Stock Price Today?
The Innopharmax stock price today is 16.00.
What Is the Stock Symbol for Innopharmax?
The stock symbol for Innopharmax is "4172."
What Stock Exchange Does Innopharmax Trade On?
Innopharmax is listed and trades on the TPEX stock exchange.
Is Innopharmax a Good Stock to Buy?
Determining whether Innopharmax—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4172 quote. (ISIN: TW0004172002)
TPEX
Currency in TWD
16.00
+0.10(+0.63%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.60
16.05
52 wk Range
11.20
23.75
4172 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.6016.05
52 wk Range
11.2023.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4172 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Innopharmax Company Profile
InnoPharmax Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of oncology and other specialties in Taiwan. The company offers Imipenem and Cilastatin sodium solution under the Bestnem brand for the treatment of infections caused by susceptible organisms, such as lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, bone, and joint infections; contrast agents, such as gadopentetate dimeglumine under the Gadomni brand; oncology agents comprising bendamustine under the Innomustine brand; immunological agents under the Immurin brand; and Inpheno tablets for rare diseases. It also provides active pharmaceutical ingredient, including orphan drug and MRI enhancing agents. In addition, the company’s product pipeline comprises D07001, which is in initiated phase II trial for treatment of pancreatic and lung cancer, as well as in phase III clinical trial to treat biliary tract cancer; D0191801, which is in preclinical trial to treat diabetes; D0221901, which is in preclinical trial to treat type II diabetes; D0282102 for the treatment of lymphocytic leukemia/multiple myeloma/non-hodgkin's lymphoma; O0242001-1, O0242001-2, O0242001-3 which is in preclinical trial to treat MRI agent. Further, it provides MUCR system, OralPas, and OralPas Pro technology platform. The company was founded in 1994 and is based in Taipei, Taiwan.
Compare 4172 to Peers and Sector
Metrics to compare | 4172 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4172PeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.1x | −8.8x | −0.5x | |
PEG Ratio | 0.97 | 0.02 | 0.00 | |
Price/Book | 3.1x | 2.6x | 2.6x | |
Price / LTM Sales | 30.9x | 8.2x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 46.0% | |
Fair Value Upside | Unlock | −8.5% | 5.4% | Unlock |
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.47 / --
Revenue / Forecast
46.64M / --
FAQ
What Is the Innopharmax (4172) Stock Price Today?
The Innopharmax stock price today is 16,00
What Stock Exchange Does Innopharmax Trade On?
Innopharmax is listed and trades on the Taipei Exchange.
What Is the Stock Symbol for Innopharmax?
The stock symbol for Innopharmax is "4172."
What Is the Innopharmax Market Cap?
As of today, Innopharmax market cap is 1,72B.
What Is Innopharmax's Earnings Per Share (TTM)?
The Innopharmax EPS (TTM) is -1,03.
From a Technical Analysis Perspective, Is 4172 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Innopharmax Stock Split?
Innopharmax has split 4 times.
How Many Employees Does Innopharmax Have?
Innopharmax has 33 employees.
What is the current trading status of Innopharmax (4172)?
As of Feb 18, 2026, Innopharmax (4172) is trading at a price of 16,00, with a previous close of 14,15. The stock has fluctuated within a day range of 15,60 to 16,05, while its 52-week range spans from 11,20 to 23,75.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.